1. Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen. (1st November 2020) Authors: van Wyk, Jean; Orkin, Chloe; Rubio, Rafael; Bogner, Johannes; Baker, David; Khuong-Josses, Marie-Aude; Parks, David; Angelis, Konstantinos; Kahl, Lesley P.; Matthews, Jessica; Wang, Ruolan; Underwood, Mark; Wynne, Brian; Nascimento, Maria-Claudia; Vandermeulen, Kati; Gartland, Martin; Smith, Kimb... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2. (1st September 2022) Authors: Llibre, Josep M.; López Cortés, Luis Fernando; Aylott, Alicia; Wynne, Brian; Matthews, Jessica; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; van Wyk, Jean; Kahl, Lesley P. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 91:Number 1(2022) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine. (1st June 2021) Authors: van Wyk, Jean; Ait-Khaled, Mounir; Santos, Jesus; Scholten, Stefan; Wohlfeiler, Michael; Ajana, Faïza; Jones, Bryn; Nascimento, Maria-Claudia; Tenorio, Allan R.; Smith, Don E.; Wright, Jonathan; Wynne, Brian Journal: Journal of acquired immune deficiency syndromes Issue: Volume 87:Number 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study. (1st June 2021) Authors: van Wyk, Jean; Ait-Khaled, Mounir; Santos, Jesus; Scholten, Stefan; Wohlfeiler, Michael; Ajana, Faïza; Jones, Bryn; Nascimento, Maria-Claudia; Tenorio, Allan R.; Smith, Don E.; Wright, Jonathan; Wynne, Brian Journal: Journal of acquired immune deficiency syndromes Issue: Volume 87:Number 2(2021) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review. (10th February 2022) Authors: Llibre, Josep M; Cahn, Pedro E; Lo, Janet; Barber, Tristan J; Mussini, Cristina; van Welzen, Berend J; Hernandez, Beatriz; Donovan, Cynthia; Kisare, Michelle; Sithamparanathan, Myooran; van Wyk, Jean Journal: Open forum infectious diseases Issue: Volume 9:Number 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dolutegravir-based regimens in treatment-naive and treatment-experienced aging populations: analyses of 6 phase III clinical trials. Issue 2 (13th July 2021) Authors: Spinelli, Frank; Prakash, Manyu; Slater, Jill; van der Kolk, Mike; Bassani, Niccolò; Grove, Richard; Wynne, Brian; van Wyk, Jean; Clark, Andrew Journal: HIV research & clinical practice Issue: Volume 22:Issue 2(2021) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV. (1st October 2021) Authors: Rolle, Charlotte-Paige; Berhe, Mezgebe; Singh, Tulika; Ortiz, Roberto; Wurapa, Anson; Ramgopal, Moti; Leone, Peter A.; Matthews, Jessica E.; Dalessandro, Marybeth; Underwood, Mark R.; Angelis, Konstantinos; Wynne, Brian R.; Merrill, Deanna; Nguyen, Christopher; van Wyk, Jean; Zolopa, Andrew R. Journal: AIDS Issue: Volume 35:Number 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dolutegravir/rilpivirine 2-drug regimen comparable to commonly prescribed 3-drug regimens up to 18-months in a real-world setting. Issue 1 (20th January 2022) Authors: Pierone, Gerald; Fusco, Jennifer S; Vannappagari, Vani; Brunet, Laurence; Weber, Rachel P; Aboud, Michael; van Wyk, Jean; Ragone, Leigh; Fusco, Gregory P Journal: Antiviral therapy Issue: Volume 27:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. (1st March 2020) Authors: Cahn, Pedro; Madero, Juan Sierra; Arribas, José R.; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E.; Hung, Chien-Ching; Rockstroh, Jürgen K.; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Brandon, Daisy J.; Underwood, Mark; Tenorio, Allan R.; Pappa, Keith A.; Wynne, ... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 83:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 10281 (3rd April 2021) Authors: Lockman, Shahin; Brummel, Sean S; Ziemba, Lauren; Stranix-Chibanda, Lynda; McCarthy, Katie; Coletti, Anne; Jean-Philippe, Patrick; Johnston, Ben; Krotje, Chelsea; Fairlie, Lee; Hoffman, Risa M; Sax, Paul E; Moyo, Sikhulile; Chakhtoura, Nahida; Stringer, Jeffrey SA; Masheto, Gaerolwe; Korutaro, Vi... Journal: Lancet Issue: Volume 397:Issue 10281(2021) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗